Jazz’s toehold on sleep market slips with tentative Avadel FDA approval
Merck’s Keytruda fails head and neck cancer trial
Biogen posts solid quarter but pipeline slims ahead of key data for its second controversial Alzheimer's drug
Gene therapy for ovarian cancer fails PhIII study
*please scroll down for all the latest news*
